Nintedanib inhibits normal human vitreous-induced epithelial-mesenchymal transition in human retinal pigment epithelial cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nintedanib inhibits normal human vitreous-induced epithelial-mesenchymal transition in human retinal pigment epithelial cells

Published:2023-10 Issue: Volume:166 Page:115403
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Yin Yiwei^ORCID,Liu Shikun,Liu Hanhan,Wu Wenyi

Funder

Natural Science Foundation of Hunan Province

Science and Technology Program of Hunan Province

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference57 articles.

1. Proliferative vitreoretinopathy: a new concept of disease pathogenesis and practical consequences;Pastor;Prog. Retin. Eye Res.,2016

2. Is neutralizing vitreal growth factors a viable strategy to prevent proliferative vitreoretinopathy?;Pennock;Prog. Retin. Eye Res.,2014

3. Proliferative vitreoretinopathy: current and emerging treatments;Sadaka;Clin. Ophthalmol.,2012

4. Prediction of proliferative vitreoretinopathy after retinal detachment surgery: potential of biomarker profiling;Ricker;Am. J. Ophthalmol.,2012

5. BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro;Yao;FASEB J.,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critical role of apoptosis in MeCP2‐mediated epithelial–mesenchymal transition of ARPE‐19 cells;Journal of Cellular Physiology;2024-09-05

2. Evaluation of nintedanib efficacy: Attenuating the lens fibrosis in vitro and vivo;International Immunopharmacology;2024-07

3. Isorhamnetin suppresses the epithelial-mesenchymal transition of the retinal pigment epithelium both in vivo and in vitro through Nrf2-dependent AKT/GSK-3β pathway;Experimental Eye Research;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3